Annual report pursuant to Section 13 and 15(d)

Series S Convertible Preferred Stock - Additional Information (Details)

v3.24.1.u1
Series S Convertible Preferred Stock - Additional Information (Details)
$ in Millions
Dec. 28, 2022
USD ($)
shares
Dec. 30, 2023
vote
shares
Dec. 31, 2022
shares
Jan. 01, 2022
shares
Dr. Soin | Related Party        
Class of Stock [Line Items]        
Common stock, shares outstanding, percentage 4.99%      
Stock Conversion 3 | Dr. Soin | Related Party        
Class of Stock [Line Items]        
Percentage of gross revenue 5.00%      
Series S        
Class of Stock [Line Items]        
Preferred stock, conversion ratio   1    
Convertible preferred stock, shares outstanding (in shares) | shares   100,000 100,000 0
Convertible preferred stock, voting rights | vote   1    
Series S | Soin Therapeutics LLC        
Class of Stock [Line Items]        
Potential value $ 30      
Company tendered, shares (in shares) | shares 100,000      
Series S | Stock Conversion 1 | Dr. Soin | Related Party        
Class of Stock [Line Items]        
Conversion of stock, amount converted $ 3      
Conversion of stock, commencement period 1 year      
Series S | Stock Conversion 2 | Dr. Soin | Related Party        
Class of Stock [Line Items]        
Conversion of stock, amount converted $ 10      
Series S | Stock Conversion 3 | Dr. Soin | Related Party        
Class of Stock [Line Items]        
Conversion of stock, amount converted $ 17      
Conversion of stock, period after closing 10 years